Back

Anti-interleukin therapy for severe asthma and left atrial function improvement: a pilot study

12 December 2025 (08:30 - 17:15)
Organised by: Logo
Congress Presentation Part of: Poster session 2 Tissue Doppler, Speckle Tracking and Strain Imaging EACVI Premium Access EACVI 2025 European Association of Cardiovascular Imaging (EACVI)

About the speaker

Photo
Doctor Mario Russo

University of Siena, Siena (Italy)

71 More presentations in this session

Presentation thumbnail
Select episodes of acute cardiac rejection after orthotopic heart transplantation, not affecting the global longitudinal strain during a 2-year observation period
Miss Z. Zalewska (Wroclaw, PL)
Abstract Slides
Presentation thumbnail
Left atrial phasic mechanics and structural predictors of target organ damage in dipper and non-dipper hypertension
Assistant Professor O. Seckin (Ankara, TR)
Abstract Slides
Presentation thumbnail
Early prediction of atrial fibrillation using left atrial strain in STEMI patients: a prospective echocardiographic study
Doctor D. Raimoglou (Istanbul, TR) Doctor H. Verdiyev (Istanbul, TR)
Abstract
Presentation thumbnail
Prognosis values of 3D strain in untreated hypertension
Professor W. Tsai (Tainan, TW)
Abstract Slides
Presentation thumbnail
Detection of right ventricular dysfunction through right ventricular free wall strain in obese heart failure with preserved ejection fraction
Mr A. Kind (Berlin, DE)
Abstract Slides

Access the full session

Session thumbnail
Poster session 2

The Event

Event poster

EACVI 2025

12 December 2025 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Left atrial strain associated with distinct inflammatory and immune signature in COVID-19 patients
29 June 2021
thumbnail
Congress Presentation
Effects of mavacamten on left atrial function in hypertrophic obstructive cardiomyopathy
13 December 2024
thumbnail
Congress Presentation
Interleukin-22 inhibits right ventricular remodelling by a unique mechanism in a pulmonary artery constriction model.
30 August 2024
thumbnail
Congress Presentation
Inhibition of interleukin-6 by tocilizumab improves endothelial glycocalyx and myocardial work index in patients with rheumatoid arthritis
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources